The business strategies of companies involved in chiral drug development were cast into doubt in October after Eli Lilly (Indianapolis, IL) decided not to pursue the development of R-fluoxetine ...

The relevance of chiral technology is particularly pronounced in the pharmaceutical industry, where the different enantiomers of a drug can have different therapeutic effects or side effects.

Developing racemic (mixed-enantiomer) drugs is on the way out, industry analysts say, because pharmaceutical companies must evaluate the individual enantiomers and the combination. "Nearly every ...

"This approach offers unprecedented and relatively easy access to a broad set of chiral carbocycles that are privileged structures for pharma industry drug discovery programs," says study senior ...

A team of researchers from China and the US has introduced a new method to improve the performance of high-enthalpy elastic ...

Understanding and controlling chirality at the nanoscale is crucial for various applications, including drug development, catalysis, and materials science. Chiral Au nanorod and its helicity map that ...

Understand the significant growth trajectory of the Intermediates segment, which is expected to reach US$8.2 Billion by 2030 with a CAGR of a 3.4%. The Analytical segment is also set to grow at 4.8% ...